Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4 Suppl
pubmed:dateCreated
1984-5-15
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0090-4295
pubmed:author
pubmed:issnType
Print
pubmed:volume
23
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
110-7
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed-meshheading:6538712-Acute Kidney Injury, pubmed-meshheading:6538712-Adult, pubmed-meshheading:6538712-Aged, pubmed-meshheading:6538712-Carcinoma, Transitional Cell, pubmed-meshheading:6538712-Cisplatin, pubmed-meshheading:6538712-Combined Modality Therapy, pubmed-meshheading:6538712-Creatinine, pubmed-meshheading:6538712-Drug Administration Schedule, pubmed-meshheading:6538712-Drug Evaluation, pubmed-meshheading:6538712-Drug Tolerance, pubmed-meshheading:6538712-Female, pubmed-meshheading:6538712-Humans, pubmed-meshheading:6538712-Leukopenia, pubmed-meshheading:6538712-Male, pubmed-meshheading:6538712-Middle Aged, pubmed-meshheading:6538712-Nausea, pubmed-meshheading:6538712-Random Allocation, pubmed-meshheading:6538712-Thrombocytopenia, pubmed-meshheading:6538712-Urinary Bladder Neoplasms, pubmed-meshheading:6538712-Vomiting
pubmed:year
1984
pubmed:articleTitle
Cisplatin as adjunctive treatment for invasive bladder carcinoma: tolerance and toxicities.
pubmed:publicationType
Journal Article, Clinical Trial, Comparative Study, Research Support, U.S. Gov't, P.H.S., Randomized Controlled Trial